Literature DB >> 2199528

Identification of a high-virulence clone of serotype III Streptococcus agalactiae by growth characteristics at 40 degrees C.

S J Mattingly1, J J Maurer, E K Eskew, F Cox.   

Abstract

A high-virulence clone of serotype III Streptococcus agalactiae causing invasive neonatal disease was previously identified by multilocus enzyme electrophoresis. A simple procedure involving growth at 40 degrees C distinguished all isolates classified in this high-virulence clone from other serotype III isolates, which are more frequently associated with asymptomatically colonized infants, as well as the other serotypes of group B streptococci. The high-virulence clone failed to grow at 40 degrees C in FMC, a chemically defined medium, in contrast to the other organisms, which grew readily.

Entities:  

Mesh:

Year:  1990        PMID: 2199528      PMCID: PMC268017          DOI: 10.1128/jcm.28.7.1676-1677.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  6 in total

1.  Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci.

Authors:  T W Milligan; C J Baker; D C Straus; S J Mattingly
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

2.  Growth and amino acid requirements of various strains of group B streptococci.

Authors:  T W Milligan; T I Doran; D C Straus; S J Mattingly
Journal:  J Clin Microbiol       Date:  1978-01       Impact factor: 5.948

3.  Growth of several cariogenic strains of oral streptococci in a chemically defined medium.

Authors:  B Terleckyj; N P Willett; G D Shockman
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

4.  Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease.

Authors:  J M Musser; S J Mattingly; R Quentin; A Goudeau; R K Selander
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

5.  In vitro method to differentiate isolates of type III Streptococcus agalactiae from symptomatic and asymptomatic patients.

Authors:  J J Maurer; S J Mattingly
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

6.  Association of elevated levels of cellular lipoteichoic acids of group B streptococci with human neonatal disease.

Authors:  T J Nealon; S J Mattingly
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

  6 in total
  5 in total

1.  High-virulence clone of group B streptococci unable to grow at high temperatures is present in serotypes other than type III.

Authors:  Gerardo C Palacios; Maria N Gonzalez; Magdalena Beltran; Jose L Arredondo; Javier Torres; Fortino Solorzano
Journal:  Curr Microbiol       Date:  2006-12-13       Impact factor: 2.188

2.  New genetic techniques for group B streptococci: high-efficiency transformation, maintenance of temperature-sensitive pWV01 plasmids, and mutagenesis with Tn917.

Authors:  P E Framson; A Nittayajarn; J Merry; P Youngman; C E Rubens
Journal:  Appl Environ Microbiol       Date:  1997-09       Impact factor: 4.792

3.  Characterization of Streptococcus agalactiae strains by randomly amplified polymorphic DNA analysis.

Authors:  S Chatellier; C Ramanantsoa; P Harriau; K Rolland; A Rosenau; R Quentin
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

4.  Loss of catabolic function in Streptococcus agalactiae strains and its association with neonatal meningitis.

Authors:  Anne-Sophie Domelier; Nathalie van der Mee-Marquet; Adeline Grandet; Laurent Mereghetti; Agnès Rosenau; Roland Quentin
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

5.  Prophagic DNA fragments in Streptococcus agalactiae strains and association with neonatal meningitis.

Authors:  Nathalie van der Mee-Marquet; Anne-Sophie Domelier; Laurent Mereghetti; Philippe Lanotte; Agnès Rosenau; Willem van Leeuwen; Roland Quentin
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.